The timing and impact of follow-up studies after normal stress single-photon emission computed tomography sestamibi studies

Circulation: Cardiovascular Imaging

Volumn 3, Issue 5, 2010, Pages 520-526

  Jo Carryer, Damita ^a   Askew, J Wells ^a   Hodge, David O ^a   Miller, Todd D ^a   Gibbons, Raymond J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenosine; Cardiac gated SPECT imaging; Nuclear medicine

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; ADENOSINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; VASODILATOR AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; CHI SQUARE DISTRIBUTION; DATA BASE; DISEASE COURSE; EXERCISE TEST; HEART DISEASE; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PREDICTION AND FORECASTING; PROGNOSIS; SCINTISCANNING; TIME; UNITED STATES; UTILIZATION REVIEW;

ADENOSINE; AGED; CHI-SQUARE DISTRIBUTION; DATABASES AS TOPIC; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; HEART DISEASES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MINNESOTA; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 77957345731     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.918706     Document Type: Article

References (19)

1. Cortese DA, Smoldt RK. Healing America's ailing health care system. Mayo Clin Proc. 2006;81:492-496.
2. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001:1-22.
3. Iglehart JK. The new era of medical imaging-progress and pitfalls. N Engl J Med. 2006;354:2822-2828.
4. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001. Circulation. 2006;113:374-379. (Pubitemid 43803198)
5. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171-185. (Pubitemid 38949912)
6. Klocke FJ, Baird MG, Bateman TM, Berman DS, Carabello BA, Cerqueira MD, DeMaria AN, Kennedy JW, Lorell BH, Messer JV, O'Gara PT, Russell RO, St John Sutton MG, Udelson JE, Verani MS, Williams KA. ACC/ AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: Executive summary. J Am Coll Cardiol. 2003;42:1318-1333.
7. Hachamovitch R, Haye S, Friedman JD, Cohen I, Shaw LJ, Germano G, Berman DS. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329-1340. (Pubitemid 36438995)
8. Berman DS, Xingping K, Schisterman EF, Gerlach J, Kavanagh PB, Areeda JS, Sharir T, Hayes SW, Shaw LJ, Lewin HC, Friedman JD, Miranda R, Germano G. Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy. J Nucl Cardiol. 2001;8:428-437. (Pubitemid 32737367)
9. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in rxc contingency tables. J Am Stat Assoc. 1983;78:427-434.
10. Miller TD, Chaliki HP, Christian TF, Hodge DO, Gibbons RJ. Usefulness of worsening clinical status or exercise performance in predicting future events in patients with coronary artery disease. Am J Cardiol. 2001;88:1294-1297. (Pubitemid 33132099)
11. Iskandrian AE, Garcia EV, Faber T. Analysis of serial images: A challenge and an opportunity. J Nucl Cardiol. 2008;15:23-26. (Pubitemid 351168513)
12. Brindis RG, Douglas PS, Hendel RC, Peterson ED, Wolk MJ, Allen JM, Patel MR, Raskin IE, Bateman TM, Cerqueira MD, Gibbons RJ, Gillam LD, Gillespie JA, Iskandrian AE, Jerome SD, Krumholz HM, Messer JV, Spertus JA, Stowers SA. ACCF/ASNC appropriateness criteria for singlephoton emission computed tomography myocardial perfusion imaging (SPECT MPI). J Am Coll Cardiol. 2005;46:1587-1605.
13. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA. ACCF/ASNC/ACR/AHA/ASE/ SCCT/SCMR/SNM 2009 appropriate use criteria for radionuclide imaging. Circulation. 2009;119:e561-e587.
14. Wennberg JE, Birkmeyer JD, Birkmeyer NJO. The Dartmouth Atlas of Cardiovascular Health Care. Chicago, IL: AHA Press, 1999.
15. National Quality Forum. Efficiency: Imaging efficiency. http://www. qualityforum.org/projects/imaging-efficiency.aspx?section- SteeringCommitteeMeeting2010-02-232010-02-24. Accessed March 31, 2010.
16. Levin DC, Rao VM, Parker L, Frangos AJ, Intenzo CM. Recent payment and utilization trends in radionuclide myocardial perfusion imaging: Comparison between self-referral and referral to radiologists. J Am Coll Radiol. 2009;6:437-441.
17. Kwok J, Christian TF, Miller TD, Hodge DO, Gibbons RJ. Incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium 201 imaging in patients with ST-T abnormalities on their resting electrocardiograms. Am Heart J. 2005;149:145-151. (Pubitemid 40126502)
18. Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol. 2004;11:551-561. (Pubitemid 39341800)
19. Hachamovitch R, Kang X, Amanullah AM, Abidov A, Hayes SW, Friedman JD, Cohen I, Thomson L, Germano G, Berman DS. Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly. Circulation. 2009;120:2197-2206.